Related Experiment Video
Updated: Mar 19, 2026

12:09
Studying Food Reward and Motivation in Humans
Published on: March 19, 2014
24.3K
Advancing Understanding of Treatment Response in Schizophrenia With Psychosis Using a Novel Dynamic Reward Task
Ju-Chun Pei1, Chia-Yuan Chang1, Ya-Wen Liu1
1Department of Psychology, National Taiwan University, Taipei, Taiwan.
Schizophrenia Bulletin
|May 27, 2025
Summary
Neurocognitive assessments, including the Dynamic Reward Task (DRT), help predict antipsychotic treatment response in schizophrenia. Impaired reward processing and executive function identified by DRT and other tests may guide personalized schizophrenia treatment.
Area of Science:
- Neuroscience
- Psychiatry
- Cognitive Science
Background:
- Schizophrenia treatment is challenging due to medication resistance.
- Impaired reinforcement learning may correlate with symptom severity and dopamine abnormalities.
- Understanding neurocognitive profiles is crucial for predicting antipsychotic treatment response.
Purpose of the Study:
- To investigate if neurocognitive profiles from the Dynamic Reward Task (DRT) predict treatment response in schizophrenia patients.
- To assess choice strategies and model-fitting parameters in relation to antipsychotic efficacy.
Main Methods:
- Neurocognitive assessments were performed on chronic schizophrenia patients with psychotic relapse, categorized by treatment response (high vs. low).
- Tests included the Dynamic Reward Task (DRT) for reward processing, Wisconsin Card Sorting Test (WCST) for executive function, and Continuous Performance Test (CPT) for sustained attention.
- Statistical analyses compared task performance between groups and pre/post-treatment.
Main Results:
- Significant differences in DRT scores, choice strategies, and model-fitting parameters were observed between high- and low-response groups.
- All schizophrenia groups showed consistent abnormalities in WCST and CPT compared to controls.
- Treatment effects varied significantly across response groups in DRT measures.
Conclusions:
- DRT, WCST, and CPT are effective in identifying neurocognitive profiles related to schizophrenia treatment response.
- The DRT specifically differentiated between high- and low-response patients.
- Deficits in reward processing and executive function may indicate personalized antipsychotic treatment strategies.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
653
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
653
Psychosis and Antipsychotic Drugs: Overview
1.1K
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.1K
Drug Therapy
376
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
376

